Integer Holdings to Hold Oct. 21 Vote on KKR-Backed Merger, Faces Three Stockholder Lawsuits

Integer Holdings (ITGR) will hold a stockholder vote on Oct. 21 regarding a KKR-backed merger. The company faces three lawsuits alleging proxy statement deficiencies and has added disclosures to mitigate risks. Goldman Sachs' DCF analysis estimates a per-share range of $98.93–$140.68, assuming ~35M diluted shares and ~$1.257B debt.

Original reporting
Published Oct 14, 2026, 12:53 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 14, 2026, 1:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Integer Holdings to Hold Oct. 21 Vote on KKR-Backed Merger, Faces Three Stockholder Lawsuits — source image
Decision brief

The 30-second read

$ITGRBearishHigh
01

Why it matters

The filing introduces new legal risk, which may depress the share price ahead of the vote, but also clarifies the deal terms for investors.

02

Market read

Primary disclosure of merger‑related litigation that could affect the stock's short‑term trajectory.

03

What to watch

Possible settlement of lawsuits before the vote or a higher‑than‑expected DCF valuation could mitigate downside.

Relevance 7/10Novelty 8/10Timing: ahead of the Oct. 21 merger vote

Background

Integer Holdings is a US‑listed micro‑cap pursuing a merger backed by KKR; the proxy supplement addresses shareholder concerns.

Company-level read

Ticker impact

$ITGRBearishHigh confidence
Context

Integer Holdings filed a supplemental proxy and disclosed three shareholder lawsuits ahead of the Oct. 21 merger vote.

Expected impact

likely pressure as investors price in lawsuit risk and uncertainty over the merger outcome

Evidence & confidence

New litigation and proxy supplement are primary disclosures; market typically reacts negatively to merger‑related lawsuits.

Market effects

Potential ripple in the specialty finance/asset‑management sector as peers assess merger risk.

US small‑cap market may see modest volatility around the vote date.

Limited to investors tracking US micro‑cap M&A activity.

Counterpoint

If the merger proceeds despite lawsuits, the premium could boost the stock sharply.

Key entities

  • Integer Holdings Corp

    Issuer of the merger and proxy filing.

  • KKR

    Backer of the proposed merger.

Related articles

$ITGRMed

Integer: Q3 Earnings Snapshot

Integer Holdings Corp. (ITGR) reported Q3 earnings of $15M, or 43 cents per share, and adjusted earnings of $1.34 per share, missing analysts' estimates of $1.65 per share. Revenue was $449.7M, also below expectations of $457.3M.

$ITGRHighAI 8/10

Integer Holdings Corporation Reports Third Quarter 2026 Results

Integer Holdings Corp (ITGR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EXHIBIT 99.1 Integer Holdings Corporation Reports Third Quarter 2026 Results PLANO, Texas, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced results for the three months ended October 2, 2026. Third Quarter 2026 Highlights (compared to Thi

$ITGRHighAI 9/10

Integer shareholders approve getting acquired by KKR

Integer (ITGR) shareholders approved a $5.7B acquisition by KKR. The vote was 26,065,335 for, 10,513 against, with 1,993 abstaining. The deal, announced in August, is expected to close by the end of 2026, pending regulatory approvals. Integer is a medical device CDMO serving cardiovascular and neuromodulation markets. The company expects increased flexibility and long-term capital as a KKR portfolio company.